Medytox
Pre-Approval PRO BETAAlso known as: Medy-Tox, Medytox Korea
Stale Activity
No new clinical trials started in 2+ years. Activity may be declining or company may be focusing on existing programs. Last trial started: 2/7/2022
Pipeline by Phase
Therapeutic Focus
Clinical Trials (42)
MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL)
Started: 10/23/2019
MT10109L in the Treatment of Lateral Canthal Lines
Started: 12/20/2018
MT10109L in the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar Lines
Started: 11/5/2018
MT10109L in the Treatment of Glabellar Lines (GL) With or Without Concurrent Treatment of Lateral Canthal Lines (LCL)
Started: 10/26/2018
Evaluate the Efficacy and Safety of MT921 in Subjects With Moderate to Severe Submental Fat
Started: 12/24/2021
CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase3)
Started: 11/13/2017
The Efficacy and Safety of CUNOX® in Patients With Moderate to Severe Glabellar Lines
Started: 12/13/2018
Evaluate the Efficacy and Safety of MEDITOXIN in Treatment of Primary Axillary Hyperhidrosis
Started: 8/3/2018
MEDITOXIN® Treatment in Subject With Benign Masseteric Hypertrophy
Started: 4/9/2018
Efficacy and Safety Study of MT10107 in the Treatment of Glabella Line
Started: 1/1/2014
Efficacy and Safety of MEDITOXIN® in Cervical Dystonia
Started: 1/9/2013
Efficacy and Safety Study of Neuramis in Correction of Nasolabial Fold
Started: 2/9/2012
MEDITOXIN® Versus BOTOX® in the Treatment of Post-stroke Spasticity of the Upper Limb Spasticity
Started: 3/1/2011
Efficacy and Safety Study of Botulinum Toxin Type A to Treat Glabellar Lines
Started: 11/23/2009
Meditoxin® Treatment in Patients With Cervical Dystonia
Started: 7/6/2017
Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lines
Started: 3/30/2016
Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Essential Blepharospasm
Started: 5/25/2016
Efficacy and Safety Evaluation Study of Neuramis® Deep Lidocaine in Correction of Nasolabial Fold
Started: 6/1/2013
Long-term Extension Study to Evaluate MBA-P01 in Subjects With Moderate to Severe Glabellar Lines
Started: 2/7/2022
Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Glabellar Lines
Started: 8/30/2021
Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines
Started: 12/7/2011
Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Glabellar Lines
Started: 5/20/2019
Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Lateral Canthal Lines
Started: 5/21/2019
A Phase II Study to Evaluate the Efficacy and Safety of MT921 in Subjects With Moderate to Severe Submental Fat
Started: 9/10/2019
Efficacy and Safety Study of MT10109L in the Treatment of Glabella Line(Including a Preliminary Study to Evaluate Safety of MT10109L)
Started: 12/1/2011
Medytoxin® Treatment in Patients With Benign Masseteric Hypertrophy
Started: 10/6/2014
Study for Determine the Safety and Efficacy of Clostridium Botulinum Toxin Type A in Subjects With Cervical Dystonia
Started: 8/1/2012
A Phase II Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Moderate to Severe Glabellar Lines
Started: 12/28/2021
CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase1)
Started: 7/17/2017
Pharmacodynamic and Safety of MT10107(Botulinum Type A Neurotoxin) in Comparison to BOTOX®
Started: 9/1/2012
Pharmacokinetic/Pharmacodynamic Characteristics and Safety/Tolerability of MT921 in Healthy Subjects
Started: 7/31/2018
Pharmacodynamic and Safety of MEDITOXIN® in Healthy Male Volunteers
Started: 10/12/2017
Treatment of MEDITOXIN® in Female Patients With Idiopathic Overactive Bladder
Started: 12/13/2017
Pharmacodynamic and Safety of MBA-P01 in Healthy Male Volunteers
Started: 4/16/2018
Anhidrotic Area and Safety of MEDITOXIN in Healthy Male Valunteers
Started: 3/20/2018
Long-term Safety and Efficacy of MEDITOXIN® in Treatment Glabellar Lines
Started: 12/30/2016
MEDITOXIN® Treatment in Subjects With Post-Stroke Upper Limb Spasticity
Started: 9/6/2013
Meditoxin® Treatment in Patients With Post Stroke Upper Limb Spasticity
Started: 5/30/2016
The Efficacy and Safety of MEDITOXIN® in Children With Cerebral Palsy
Started: 8/1/2010
Efficacy and Safety Study of Meditoxin® to Treat Essential Blepharospasm
Started: 8/1/2010